Winslow Evans & Crocker’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
FAM
1WCM
Winslow Evans & Crocker's RGEN Position: Q4 2020 in Review
Winslow Evans & Crocker increased its Repligen (RGEN) stake by 12% in Q4 2020, buying an estimated $105K and bringing the position to 5,558 shares worth $1.06M. The position accounts for 0.2% of the portfolio, ranked #119.
Winslow Evans & Crocker first reported a position in RGEN in Q3 2019 and has held it in 6 quarters since. 449 funds tracked by Wall St. Rank hold RGEN as of Q4 2020.
- Winslow Evans & Crocker held 5,558 shares of Repligen worth $1.06M as of Q4 2020.
- Winslow Evans & Crocker bought 575 Repligen shares in Q4 2020, an estimated $105K.
- Repligen made up 0.2% of Winslow Evans & Crocker's portfolio in Q4 2020, its #119 holding.
- Winslow Evans & Crocker first reported a position in Repligen in Q3 2019 and has held it in 6 quarters since.
- 449 funds tracked by Wall St. Rank held Repligen as of Q4 2020.
Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.